通过肠道微生物群来管理葡萄糖平衡
Savanna N Weninger1, Andrew Manley2, Frank A Duca2
11Department of Physiological Sciences, University of Arizona, Tucson, Arizona, USA.
Annual review of physiology
|September 17, 2025
概括
肠道微生物群显著影响2型糖尿病 (T2D) 的发展. 通过益生菌等疗法操纵肠道细菌为代谢疾病提供了有前途的新疗法.
科学领域:
- 微生物学 微生物学
- 代谢疾病 代谢疾病
- 胃肠病学 胃肠病学
背景情况:
- 肠道微生物群在宿主新陈代谢和免疫功能中起着至关重要的作用.
- 肠道细菌与宿主之间的复杂相互作用会影响代谢的恒常性.
- 肠道微生物群的失生症越来越多地与2型糖尿病 (T2D) 的发病有关.
研究的目的:
- 审查肠道微生物群对T2D发展的影响.
- 探索针对T2D的肠道微生物群的当前和新型治疗策略.
- 突出替代治疗方法,如便微生物种移植,益生菌,益生菌,共生菌和异生菌.
主要方法:
- 对研究肠道微生物群和T2D的文献综述.
- 分析肠道微生物群在代谢交叉对话中的作用背后的机制.
- 评估旨在调节肠道微生物群的治疗干预措施.
主要成果:
- 在T2D患者中,肠道微生物群的组成和功能发生了显著的变化.
- 饮食因素极大地影响肠道微生物群,影响代谢健康.
- 针对肠道微生物群的新兴疗法显示出对T2D管理的潜力.
结论:
- 了解肠道微生物群在T2D病因学中的作用对于开发有效的治疗方法至关重要.
- 准肠道微生物群为新型T2D治疗策略提供了一个有希望的前沿.
- 对基于微生物群的干预措施的进一步研究可能会导致改善T2D的个性化方法.
相关概念视频
Glucose Homeostasis: Regulation of Blood Glucose
3.9K
Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
3.9K
Glucose Absorption Into the Small Intestine
35.1K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
35.1K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.2K
Hormones Regulating Blood Glucose
6.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.5K
Overview of Carbohydrate Metabolism
3.3K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
3.3K
Glucagon-like Receptor Agonists
850
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
850


